美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72162-2663-4	72162-2663	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20260609	N/A	ANDA	ANDA207658	Bryant Ranch Prepack	TEMOZOLOMIDE	180 mg/1	14 CAPSULE in 1 BOTTLE (72162-2663-4)
72162-2664-2	72162-2664	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20260609	N/A	ANDA	ANDA207658	Bryant Ranch Prepack	TEMOZOLOMIDE	250 mg/1	5 CAPSULE in 1 BOTTLE (72162-2664-2)
82249-404-05	82249-404	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	5 mg/1	5 CAPSULE in 1 BOTTLE (82249-404-05)
82249-404-14	82249-404	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	5 mg/1	14 CAPSULE in 1 BOTTLE (82249-404-14)
82249-406-05	82249-406	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	20 mg/1	5 CAPSULE in 1 BOTTLE (82249-406-05)
82249-406-14	82249-406	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	20 mg/1	14 CAPSULE in 1 BOTTLE (82249-406-14)
82249-408-05	82249-408	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	100 mg/1	5 CAPSULE in 1 BOTTLE (82249-408-05)
82249-408-14	82249-408	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	100 mg/1	14 CAPSULE in 1 BOTTLE (82249-408-14)
82249-410-05	82249-410	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	140 mg/1	5 CAPSULE in 1 BOTTLE (82249-410-05)
82249-410-14	82249-410	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	140 mg/1	14 CAPSULE in 1 BOTTLE (82249-410-14)
82249-412-05	82249-412	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	180 mg/1	5 CAPSULE in 1 BOTTLE (82249-412-05)
82249-412-14	82249-412	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	180 mg/1	14 CAPSULE in 1 BOTTLE (82249-412-14)
82249-414-05	82249-414	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	CivicaScript LLC	TEMOZOLOMIDE	250 mg/1	5 CAPSULE in 1 BOTTLE (82249-414-05)
73043-011-05	73043-011	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	5 mg/1	5 CAPSULE in 1 BOTTLE (73043-011-05)
73043-011-14	73043-011	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	5 mg/1	14 CAPSULE in 1 BOTTLE (73043-011-14)
73043-012-05	73043-012	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	20 mg/1	5 CAPSULE in 1 BOTTLE (73043-012-05)
73043-012-14	73043-012	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	20 mg/1	14 CAPSULE in 1 BOTTLE (73043-012-14)
73043-013-05	73043-013	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	100 mg/1	5 CAPSULE in 1 BOTTLE (73043-013-05)
73043-013-14	73043-013	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	100 mg/1	14 CAPSULE in 1 BOTTLE (73043-013-14)
73043-014-05	73043-014	HUMAN PRESCRIPTION DRUG	Temozolomide	Temozolomide	CAPSULE	ORAL	20250401	N/A	ANDA	ANDA207658	Devatis, Inc.	TEMOZOLOMIDE	140 mg/1	5 CAPSULE in 1 BOTTLE (73043-014-05)